On Nov 06, major Wall Street analysts update their ratings for $Masimo (MASI.US)$, with price targets ranging from $170 to $180.
Wells Fargo analyst Vik Chopra maintains with a buy rating, and adjusts the target price from $160 to $171.
Needham analyst Michael Matson maintains with a hold rating.
BTIG analyst Marie Thibault maintains with a buy rating, and maintains the target price at $178.
Piper Sandler analyst Jason Bednar maintains with a buy rating, and adjusts the target price from $165 to $180.
Raymond James analyst Jayson Bedford upgrades to a buy rating, and sets the target price at $170.
Furthermore, according to the comprehensive report, the opinions of $Masimo (MASI.US)$'s main analysts recently are as follows:
The firm's outlook on Masimo is positive, recognizing the rapid actions of the new management and board to improve the company's profit and loss statement. With solid growth in consumables revenue and successful hospital contracting, the expectation is that Masimo will exceed performance projections in the fourth quarter and continue strong performance into 2025.
The outlook for Masimo has adjusted post-quarterly results, with anticipation for an operational margin of at least 26% for its stand-alone healthcare operations by 2025, reflecting a 200 basis points increase from past projections. A further strategic update is anticipated in January.
Here are the latest investment ratings and price targets for $Masimo (MASI.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
